Posts by: Ana Pamplona

Ana Pamplona

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

January 7, 2015January 7, 2015

Antibody Levels Predict Mortality in Early Rheumatoid Arthritis

News

In inflammatory arthritis, autoantibodies rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) have been associated with poor outcomes, such as increased disease activity, radiographic progression and disability. A new study ... Read more

December 22, 2014December 22, 2014

Rare Rheumatoid Arthritis Complication Treated with Rituximab

News

Rheumatoid Arthritis (RA) combined with characteristics of Pulmonary Lymphomatoid Granulomatosis (PLG) is a rare lung disorder with multiple nodular lesions with lymphocytic invasion of vascular walls. A new study entitled ... Read more

December 17, 2014December 17, 2014

Neovacs Rheumatoid Arthritis Drug Misses Primary Endpoint; Company Will Pivot To Lupus

News

Data from a Phase IIb clinical trial of TNF-Kinoid in Rheumatoid Arthritis (RA) was recently released by drug developer NEOVACS, a leader in the development of an active immunotherapy technology platform (Kinoids) ... Read more

December 13, 2014December 13, 2014

Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients

News

During the American College of Rheumatology annual meeting held in Boston this past November, several research projects related to rheumatoid arthritis were presented. Among them, a novel blood test that could lead to ... Read more